Search Results - "Rao, Ravi D."

Malignant melanoma in the 21st century, Part 1: Epidemiology, risk factors, screening, prevention, and diagnosis by MARKOVIC, Svetomir N, ERICKSON, Lori A, LAMAN, Susan D, KOTTSCHADE, Lisa A, MAPLES, William J, PITTELKOW, Mark R, PULIDO, Jose S, CAMERON, J. Douglas, CREAGAN, Edward T, RAO, Ravi D, WEENIG, Roger H, POCKAJ, Barbara A, BARDIA, Aditya, VACHON, Celine M, SCHILD, Steven E, MCWILLIAMS, Robert R, HAND, Jennifer L

“…Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The incidence of melanoma has been steadily increasing worldwide, resulting…”
Get full text

Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis by Markovic, Svetomir N., MD, PhD, Erickson, Lori A., MD, Rao, Ravi D., MBBS, McWilliams, Robert R., MD, Kottschade, Lisa A., RN, Creagan, Edward T., MD, Weenig, Roger H., MD, Hand, Jennifer L., MD, Pittelkow, Mark R., MD, Pockaj, Barbara A., MD, Bardia, Aditya, MD, Vachon, Celine M., PhD, Schild, Steven E., MD, Laman, Susan D., MD, Maples, William J., MD, Pulido, Jose S., MD, MS, MPH, MBA, Cameron, J. Douglas, MD

“…Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The incidence of melanoma has been steadily increasing worldwide, resulting…”
Get full text

Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment by Markovic, Svetomir N., MD, PhD, Erickson, Lori A., MD, Rao, Ravi D., MBBS, Weenig, Roger H., MD, Pockaj, Barbara A., MD, Bardia, Aditya, MD, Vachon, Celine M., PhD, Schild, Steven E., MD, McWilliams, Robert R., MD, Hand, Jennifer L., MD, Laman, Susan D., MD, Kottschade, Lisa A., RN, Maples, William J., MD, Pittelkow, Mark R., MD, Pulido, Jose S., MD, MS, MPH, MBA, Cameron, J. Douglas, MD, Creagan, Edward T., MD

“…Critical to the clinical management of a patient with malignant melanoma is an understanding of its natural history. As with most malignant disorders,…”
Get full text

The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism by Loprinzi, Charles L, Maddocks-Christianson, Kami, Wolf, Sherry L, Rao, Ravi D, Dyck, P James B, Mantyh, Patrick, Dyck, Peter J

“…Paclitaxel therapy often result in a unique subacute pain syndrome, commonly termed "myalgia" or "arthralgia." The pathophysiology of this syndrome is unknown…”
Get full text

Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response by Jaeckle, Kurt A, Ballman, Karla V, Rao, Ravi D, Jenkins, Robert B, Buckner, Jan C

“…Oligodendroglioma frequently (> or = 70%) responds to radiation and chemotherapy, and is the first CNS neoplasm in which a genetic signature (1p and 19q…”
Get full text

Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells by Rao, Ravi D., Mladek, Ann C., Lamont, Jeffrey D., Goble, Jennie M., Erlichman, Charles, James, C. David, Sarkaria, Jann N.

“…Elevated epidermal growth factor receptor (EGFR) and mammalian target of rapamycin (mTOR) signaling are known to contribute to the malignant properties of…”
Get full text

Altered molecular pathways in gliomas: An overview of clinically relevant issues by Rao, Ravi D., James, C. David

“…Primary central nervous system (CNS) tumors constitute a small fraction of the overall incidence of human cancer, but they represent a major source of…”
Get full text

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3) by RAO, Ravi D, MICHALAK, John C, SLOAN, Jeff A, LOPRINZI, Charles L, SOORI, Gamini S, NIKCEVICH, Daniel A, WARNER, David O, NOVOTNY, Paul, KUTTEH, Leila A, WONG, Gilbert Y

“…The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data,…”
Get full text

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance) by Vera Aguilera, Jesus, Rao, Ravi D., Allred, Jacob B., Suman, Vera J., Windschitl, Harold E., Kaur, Judith S., Maples, William J., Lowe, Val J., Creagan, Edward T., Erickson, Lori A., Markovic, Svetomir

“…Lessons Learned Everolimus does not have sufficient activity to justify its use as single agent in metastatic melanoma. Patients treated with 10 mg per day…”
Get full text

Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic by Schomas, David A, Laack, Nadia N Issa, Rao, Ravi D, Meyer, Fredric B, Shaw, Edward G, O'Neill, Brian Patrick, Giannini, Caterina, Brown, Paul D

“…The purpose of this study was to evaluate long-term survival in patients with nonpilocytic low-grade gliomas (LGGs). Records of 314 adult patients with…”
Get full text

Efficacy of Lamotrigine in the Management of Chemotherapy-induced Peripheral Neuropathy : A Phase 3 Randomized, Double-blind, Placebo-controlled Trial, N01C3 by RAO, Ravi D, FLYNN, Patrick J, SLOAN, Jeff A, WONG, Gilbert Y, NOVOTNY, Paul, JOHNSON, David B, GROSS, Howard M, RENNO, Samer I, NASHAWATY, Mohammed, LOPRINZI, Charles L

“…Lamotrigine, an antiepileptic agent, has been reported as being effective in reducing symptoms of neuropathy associated with various etiologies. Based on such…”
Get full text

Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks by SARKARIA, Jann N, GALANIS, Eva, GIANNINI, Caterina, JAECKLE, Kurt A, BUCKNER, Jan C, WENTING WU, DIETZ, Allan B, KAUFMANN, Timothy J, GUSTAFSON, Michael P, BROWN, Paul D, UHM, Joon H, RAO, Ravi D, DOYLE, Laurence

“…The mammalian target of rapamycin (mTOR) functions within the phosphoinositide 3-kinase/Akt signaling pathway as a critical modulator of cell survival. The…”
Get full text

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis by OLSON, Janet E, JANNEY, Carol A, RAO, Ravi D, CERHAN, James R, KURTIN, Paul J, SCHIFF, David, KAPLAN, Richard S, O'NEILL, Brian Patrick

“…Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkin lymphoma arising in the craniospinal axis. The incidence of PCNSL appears…”
Get full text

Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanoma by Rao, Ravi D., Holtan, Shernan G., Ingle, James N., Croghan, Gary A., Kottschade, Lisa A., Creagan, Edward T., Kaur, Judith S., Pitot, Henry C., Markovic, Svetomir N.

“…BACKGROUND Patients with metastatic melanoma (MM) have very few therapy options. Based on reports of responses to paclitaxel and carboplatin (PC), 31 patients…”
Get full text

Intratracheal Melanoma Metastases by Bardia, Aditya, Rao, Ravi D

“…A 42-year-old woman with metastatic melanoma presented with a 1-month history of dyspnea and wheezing. The diagnosis of malignant melanoma had been made 6…”
Get full text

Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents by Rao, Ravi D, Buckner, Jan C, Sarkaria, Jann N

“…Highly specific signal transduction inhibitors are being developed as anti-cancer agents against an array of molecular targets, with the promise of increased…”
Get more information

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization by Markovic, Svetomir N, Suman, Vera J, Ingle, James N, Kaur, Judith S, Pitot, Henry C, Loprinzi, Charles L, Rao, Ravi D, Creagan, Edward T, Pittelkow, Mark R, Allred, Jakob B, Nevala, Wendy K, Celis, Esteban

“…Therapeutic peptide vaccines for melanoma continue to only demonstrate anecdotal success. We set out to evaluate the impact of low-dose GM-CSF emulsified in…”
Get full text

Melanoma-induced brain metastases by McWilliams, Robert R, Rao, Ravi D, Buckner, Jan C, Link, Michael J, Markovic, Svetomir, Brown, Paul D

“…Brain metastases are a common site of metastasis from malignant melanoma, and are associated with a poor prognosis. Diagnosis of brain metastasis may also have…”
Get full text

Chemotherapy-induced neuropathy by Bhagra, Anjali, Rao, Ravi D

“…Peripheral neuropathy is a common dose-limiting toxicity of chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) causes numerous debilitating…”
Get full text

Innovation in the management of brain metastases by Rao, Ravi D, Brown, Paul D, Buckner, Jan C

“…Metastatic lesions to the brain occur commonly in oncology patients and portend a very poor outcome, as they often occur in the setting of progressive systemic…”
Get more information